Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry
NCT04496687 · View on ClinicalTrials.gov ↗
Study Summary
The aim of "iSCAD," the International Spontaneous Coronary Artery Dissection (SCAD) Registry, is to serve as an internationally collaborative, multicenter registry coordinated by an experienced and centralized coordinating center in an effort to increase the pace of participant recruitment, and thereby increase statistical power of studies related to SCAD. The ultimate goal of iSCAD Registry is to facilitate the development of best practices and clinical guidelines for preventing SCAD or its recurrence. This observational study will be prospective and retrospective in its recruitment and will collect clinical information to better understand the natural history and prognosis for SCAD.
Conditions Studied
Study Locations (20)
California
- Cedars Sinai — Los Angeles
- UCLA (University of California, Los Angeles) — Los Angeles
- Kaiser Permanente Northern California — San Francisco
Missouri
- St. Luke's Mid America — Kansas City
- Washington University — St Louis
New Hampshire
- Dartmouth-Hitchcock — Lebanon
- Catholic Medical Center — Manchester
New York
- Mount Sinai — New York
- Columbia University Medical Center — New York
Colorado
- University of Colorado — Aurora
Connecticut
- Hartford Hospital — Hartford
Florida
- University of South Florida — Tampa
Georgia
- Emory Healthcare System — Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2019-03-08 |
| Est. Completion | 2025-12-31 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04496687
The ClinicalTrials.gov registry entry for NCT04496687 describes a study currently listed as recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SCAD Alliance, which has 1 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Spontaneous Coronary Artery Dissection appearing as the primary indexed condition, and to 0 interventions. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT04496687 reports 20 study locations spanning 15 distinct geographic areas — top geographies include California, Missouri, New Hampshire. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT04496687 about?
NCT04496687 is a clinical study titled "International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry". The aim of "iSCAD," the International Spontaneous Coronary Artery Dissection (SCAD) Registry, is to serve as an internationally collaborative, multicenter registry coordinated by an experienced and centralized coordinating center in an effort to increase the pace of participant recruitment, and ther...
What is the current status of trial NCT04496687?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2019-03-08. Estimated completion is 2025-12-31.
What conditions does trial NCT04496687 study?
This clinical trial studies the following conditions: Spontaneous Coronary Artery Dissection. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
Who is sponsoring clinical trial NCT04496687?
This trial is sponsored by SCAD Alliance, which has 1 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT04496687 being conducted?
This trial has 20 study locations across California, Colorado, Connecticut, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.